468 related articles for article (PubMed ID: 16407588)
1. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.
Bradbury MW
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G194-8. PubMed ID: 16407588
[TBL] [Abstract][Full Text] [Related]
2. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
3. Liver lipid metabolism.
Nguyen P; Leray V; Diez M; Serisier S; Le Bloc'h J; Siliart B; Dumon H
J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):272-83. PubMed ID: 18477307
[TBL] [Abstract][Full Text] [Related]
4. Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
Ginsberg HN
Cell Metab; 2006 Sep; 4(3):179-81. PubMed ID: 16950134
[TBL] [Abstract][Full Text] [Related]
5. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.
Reddy JK; Rao MS
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G852-8. PubMed ID: 16603729
[TBL] [Abstract][Full Text] [Related]
6. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice.
Arsov T; Larter CZ; Nolan CJ; Petrovsky N; Goodnow CC; Teoh NC; Yeh MM; Farrell GC
Biochem Biophys Res Commun; 2006 Apr; 342(4):1152-9. PubMed ID: 16516152
[TBL] [Abstract][Full Text] [Related]
7. Lipid metabolism in hepatic steatosis.
Bradbury MW; Berk PD
Clin Liver Dis; 2004 Aug; 8(3):639-71, xi. PubMed ID: 15331068
[TBL] [Abstract][Full Text] [Related]
8. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
Musso G; Gambino R; Cassader M
Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.
Doege H; Baillie RA; Ortegon AM; Tsang B; Wu Q; Punreddy S; Hirsch D; Watson N; Gimeno RE; Stahl A
Gastroenterology; 2006 Apr; 130(4):1245-58. PubMed ID: 16618416
[TBL] [Abstract][Full Text] [Related]
11. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
Choi SS; Diehl AM
Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
[TBL] [Abstract][Full Text] [Related]
12. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
14. Hepatic microcirculation in fatty liver disease.
Farrell GC; Teoh NC; McCuskey RS
Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
[TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism in the liver.
Canbay A; Bechmann L; Gerken G
Z Gastroenterol; 2007 Jan; 45(1):35-41. PubMed ID: 17236119
[TBL] [Abstract][Full Text] [Related]
16. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
17. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
18. Decrease of eicosapentaenoic acid in fatty liver of diabetic subjects.
Singer P; Honigmann G; Schliack V
Prostaglandins Med; 1980 Sep; 5(3):183-200. PubMed ID: 6251498
[TBL] [Abstract][Full Text] [Related]
19. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]